CONCLUSION: Inhaled
mometasone furoate is well tolerated, with minimal systemic activity and is equally effective when administered as a divided dose or as a single daily dose. Use of the
drug can result in a decrease in requirements for oral
corticosteroids in patients with oral
corticosteroid-dependent
asthma and is as effective as other inhaled
corticosteroids currently used in the treatment of mild to moderate persistent
asthma. Thus
mometasone furoate is suitable for the control of mild to severe persistent
asthma in adults or adolescents.